- ￥33
- APExBIO
- 美国
- APE-A3275-10
- 2025年07月07日
企业认证
相关产品推荐更多 >
![2-Bromo-N-[3-[(1-oxobutyl)amino]phenyl]benzamide/2-Bromo-N-[3-[(1-oxobutyl)amino]phenyl]benzamide/2-Bromo-N-[3-[(1-oxobutyl)amino]phenyl]benzamide](https://img1.dxycdn.com/2020/0710/162/1022829611896683243-14.jpg!wh200)
2-Bromo-N-[3-[(1-oxobutyl)amino]phenyl]benzamide/2-Bromo-N-[3-[(1-oxobutyl)amino]phenyl]benzamide/2-Bromo-N-[3-[(1-oxobutyl)amino]phenyl]benzamide
询价
E-钙粘蛋白阳性对照/E-Cadherin Positive Control
询价
生物素 Azide物|Biotin Azide
￥11PDE10A 阳性对照/PDE10A Positive Control
询价![Dibenz [b，e] oxepin-11（6H）-one,Dibenz[b,e]oxepin-11(6H)-one,CAS：4504-87-4](https://img1.dxycdn.com/2023/0423/153/7183716733803752163-14.jpg!wh200)
Dibenz [b，e] oxepin-11（6H）-one,Dibenz[b,e]oxepin-11(6H)-one,CAS：4504-87-4
￥11
万千商家帮你免费找货
0 人在求购买到急需产品
- 详细信息
- 文献和实验
- 技术资料
- 保存条件：
储存于-20 ° C
- 保质期：
1年
- 英文名：
Calcium-Sensing Receptor Antagonists I
- 库存：
100
- 供应商：
艾美捷科技
- CAS号：
无
- 规格：
10mg
Calcium-Sensing Receptor Antagonists I，Calcium-Sensing Receptor Antagonists I，Calcium-Sensing Receptor Antagonists I,Calcium-Sensing Receptor Antagonists I
Calcium-Sensing Receptor Antagonists I-Calcium-Sensing Receptor Antagonists I
产品货号：APE-A3275-10
产品规格：10mg
CaSR拮抗剂
GPCR/G protein|CaSR
Calcium-Sensing Receptor Antagonists I-Calcium-Sensing Receptor Antagonists I储存于-20 ° C
点击：Calcium-Sensing Receptor Antagonists I-Calcium-Sensing Receptor Antagonists I查看更详细产品说明，更多应用、储存、价格、货期等信息请垂询艾美捷科技有限公司。更多APExBIO公司特色小分子抑制剂等产品评论，请点击查看艾美捷特色产品中心。
风险提示：丁香通仅作为第三方平台，为商家信息发布提供平台空间。用户咨询产品时请注意保护个人信息及财产安全，合理判断，谨慎选购商品，商家和用户对交易行为负责。对于医疗器械类产品，请先查证核实企业经营资质和医疗器械产品注册证情况。
文献和实验Identification of Adipokine Receptor Agonists and Turning Them to Antagonists
selectivity of 1,000 in cellular assays. The design process of ObR antagonists included shortening of the peptide length and incorporating additional nonnatural residues. Here I take a look into this receptor agonist and antagonist discovery
Upregulating G Protein-Coupled Receptors with Receptor Antagonists
. This chapter reviews data that support antagonist-induced upregulation specifically of opioid receptors but many of the principles apply to other GPCRs as well. It is well documented that chronic exposure to opioid receptor antagonists
were found to be nonselective, and it was hoped that “specific antagonists” would be developed for analyzing the effects of indolealkylamines in various organisms (Gyermek, 1966).
技术资料暂无技术资料 索取技术资料
